Page last updated: 2024-08-21

lactulose and Clostridium Infections

lactulose has been researched along with Clostridium Infections in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Brandt, LJ; Feuerstadt, P; Hong, SJ	1
Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H	1
Agarwalla, A; Davey, S; Goldberg, D; Hamilton, K; Rhim, AD; Weber, A; Yang, YX	1
Bass, NM; Beavers, K; Bortey, E; Forbes, WP; Frederick, T; Hillebrand, D; Huang, S; Leevy, CB; Merchant, K; Mullen, KD; Neff, G; Poordad, F; Sanyal, A; Shaw, A; Sheikh, MY; Sigal, S; Teperman, L	1

Trials

1 trial(s) available for lactulose and Clostridium Infections

Article	Year
Rifaximin treatment in hepatic encephalopathy. The New England journal of medicine, 2010, Mar-25, Volume: 362, Issue:12 Topics: Aged; Anti-Infective Agents; Chronic Disease; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Rifamycins; Rifaximin; Secondary Prevention	2010

Article

Year

Rifaximin treatment in hepatic encephalopathy.

The New England journal of medicine, 2010, Mar-25, Volume: 362, Issue:12

Topics: Aged; Anti-Infective Agents; Chronic Disease; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Rifamycins; Rifaximin; Secondary Prevention

2010

Other Studies

3 other study(ies) available for lactulose and Clostridium Infections

Article	Year
Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection. Digestive diseases and sciences, 2020, Volume: 65, Issue:2 Topics: Aged; Anti-Bacterial Agents; Chemoprevention; Clostridioides difficile; Clostridium Infections; Diarrhea; End Stage Liver Disease; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intensive Care Units; Lactulose; Liver Cirrhosis; Male; Middle Aged; Mortality; Retrospective Studies; Rifaximin; Severity of Illness Index	2020
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:7 Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin	2020
Lactulose Is Associated With Decreased Risk of Clostridium difficile Infection in Decompensated Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:6 Topics: Aged; Case-Control Studies; Clostridium Infections; Female; Gastrointestinal Agents; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Prebiotics	2017